BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 4, 2016
View Archived Issues
Bio-Path completes the safety portion of phase II trial evaluating BP-1001 in AML
Read More
TGV Laboratories outlines discovery of MV-4 with antiviral potential
Read More
Collaboration to evaluate avelumab in combination with defactinib in ovarian cancer
Read More
Syndax prices its initial public offering
Read More
Bristol-Myers Squibb patents ROCK2 inhibitors
Read More
Tesevatinib receives FDA orphan drug designation for the treatment of ARKPD
Read More
Cornell University describes immunoproteasome inhibitors
Read More
ContraVir demonstrates safety of FV-100 in drug-drug interaction study
Read More
Versitech and State Key Laboratory of Natural Product Chemistry report agents for liver disease
Read More
Novel vaccines and blood safety measures to combat global Zika virus outbreak
Read More
Rainbow Medical and Medos collaborate to treat spinal degenerative disc disease
Read More
PRAME oncogene expression is a prognostic biomarker in uveal melanoma
Read More
Hydra Biosciences presents TRPC5 antagonists
Read More
Onconova receives notice of termination from Baxalta regarding rigosertib agreement
Read More
MediSynergics divulges antiprotozoal compounds
Read More
Merck KGaA collaborates with EMBL to study cancer metabolism
Read More
Cyclic form of AChE-derived peptide as novel therapeutic approach in Alzheimer's disease
Read More
Yuhan Corporation and Sorrento Therapeutics form joint venture company
Read More
Ensemble achieves early-stage research milestone in Alexion collaboration
Read More
FDA grants orphan drug designation to BHV-0223 for spinocerebellar ataxia
Read More
Grunenthal and Axxam collaborate in pain and inflammation
Read More
Small molecule GS-5734 protects monkeys from Ebola virus disease
Read More
CaM-dependent RyR2 inhibitor shows promise for the treatment of arrhythmias
Read More
Phase II trial investigates intraductal administration of fulvestrant in DCIS or breast cancer
Read More
Encochleated amikacin receives FDA orphan drug designation for NTM infections
Read More